Navigation Links
Day Two of AdvaMed 2013 to Feature Government and Industry Leaders on MedTech Challenges and Opportunities
Date:9/23/2013

WASHINGTON, Sept. 23, 2013 /PRNewswire-USNewswire/ -- The second day of AdvaMed 2013: The MedTech Conference at the Walter E. Washington Convention Center in Washington, D.C., will feature plenary sessions honoring two of the industry's congressional champions and exploring the impact of new Medicare payment initiatives on patient access to medical innovations.

The morning plenary session on Tuesday, "Recognizing our 2013 Congressional Champions," will feature Sen. Orrin Hatch (R-UT) and Sen. Amy Klobuchar (D-MN), leaders in the charge to repeal the medical device excise tax. Remarks will explore the need for public policy to promote the development of innovations that improve patient care. Senators Hatch and Klobuchar will each receive the AdvaMed 2013 Congressional Champion Award for their continued support of medical technology innovation.

The two-part plenary lunch, "New Directions for CMS – What You Need to Know," will feature perspectives on the changing health care payment environment from the public and private sector. CMS Administrator Marilyn Tavenner will deliver opening remarks on the agency's current priorities and their potential impact on the MedTech industry. Following her remarks, Susan Dentzer, senior policy advisor, Robert Wood Johnson Foundation, will moderate a discussion centered on the implications of CMS's future policy directions between William Gracey, president and CEO, BlueCross BlueShield of Tennessee, and former CMS Administrator Tom Scully, senior counsel, Alston & Bird LLP.

In addition to the plenary sessions, Ernst & Young will unveil its sixth annual "Pulse of the Industry" report on the state of the medical technology sector, and a series of CEOs Unplugged sessions on Tuesday will address: emerging growth company issues; health care delivery; current legislation and policy; and the MedTech value proposition and life-changing innovations. Some of the other panel discussions on Tuesday will explore: the value of diagnostics; gaining access to developing markets; payment standards; and post market surveillance.

A special feature of the conference will be Innovation Alley, where eight companies will display their life-changing innovations and cutting-edge technologies.

For a full conference agenda, visit http://www.advamed2013.com.

About AdvaMed 2013: The MedTech Conference
AdvaMed 2013: The MedTech Conference is the leading gathering in North America of global MedTech executives with regulatory, reimbursement, business development, legal, IP, marketing, quality, compliance, and other key responsibilities. Along with industry leaders, the conference attracts business development professionals, investors, policy-makers, members of the media, legal experts, consultants, distributors, and other important stakeholders will attend this international conference.

More than 2,000 attendees will network, conduct business, gain access to capital and share insights in Washington, D.C. from September 23-25.  The conference also features world-class plenary speakers, networking and business development opportunities. Visit http://advamed2013.com, follow @AdvaMed2013 on Twitter, or join the AdvaMed 2013 LinkedIn group to learn more.


'/>"/>
SOURCE AdvaMed 2013
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. International MedTech Industry a Major Focus at AdvaMed 2013
2. BioBDx to Present at the 2012 BioPharm America and AdvaMed MedTech Conferences in Boston
3. Companies Selected to Present at AdvaMed 2012 Announced
4. JTB Law Group, LLC Featured in New Jersey Legal Leaders, Top Rated Lawyers for 2013
5. Terascala Special Report Features Gartner Research to Help R&D and IT Users Accelerate Performance with HPC Storage Appliances
6. HOLLOWAY AMERICA to Feature Custom Steel Fabrication Products and Capabilities at the ISPE San Diego Chapter 21st Annual Vendor Night Exhibit Show
7. Midwest Biotech Leaders Featured On BioSpace Map
8. “Outlook” with “Ben Kingsley” Features Programming Discussing the Role of Nanotechnology in Medicine
9. Top Five Global Cardiovascular Drug Companies 2013 Report Features Players such as Pfizer and AstraZeneca
10. Islet Sciences, Inc. Technologies Featured in Five Separate Presentations at the American Diabetes Association Annual Meeting
11. Zacks Investment Ideas feature highlights: Market Vectors Biotech ETF, iShares Nasdaq Biotechnology ETF, Regeneron, Celgene and First Trust Amex Biotechnology Index Fund
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a ... discoveries to the medical community, has closed its Series ... Matthew Nunez . "We have received a ... the capital we need to meet our current goals," ... provide us the runway to complete validation on the ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest ... ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials in ...
(Date:6/23/2016)... 2016  Amgen (NASDAQ: AMGN ) today ... life sciences incubator to accelerate the development of ... space at QB3@953 was created to help high-potential life ... many early stage organizations - access to laboratory infrastructure. ... launched two "Amgen Golden Ticket" awards, providing each winner ...
(Date:6/22/2016)... Research and Markets has announced the addition of the ... The global biomarkers market ... 2013. The market is expected to grow at a five-year compound ... from $50.6 billion in 2015 to $96.6 billion in 2020. ... (2015 to 2020) are discussed. As well, new products approved in ...
Breaking Biology Technology:
(Date:4/19/2016)... UAE, April 20, 2016 The ... as a compact web-based "all-in-one" system solution for all ... fingerprint reader or the door interface with integration authorization ... access control systems. The minimal dimensions of the access ... into the building installations offer considerable freedom of design ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
Breaking Biology News(10 mins):